Aranesp is the trade name for Darbepoetin alfa, a synthetic version of erythropoietin, which stimulates the production of red blood cells. Aranesp has been used since its approval by the U.S. Food and Drug Administration (FDA) in 2001 to treat patients with anemia, as well as chronic renal failure. It has been frequently prescribed to individuals suffering anemia as a byproduct of chemotherapy.
The FDA has required black box warnings on all sales of Darbepoetin alfa in the United States, citing a number of potential adverse health risks, including:
If you experienced side effects after being prescribed Aranesp, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
While most drivers are safe and aim to obey the rules, some have some unsafe habits and violate road rules in ways that ... Read More
Court Denies Access to Green Card for Couple Who Entered Country Illegally In a rare unanimous decision on the volatile... Read More
There are numerous ways that someone can lose their house in a divorce, with the most common reason being that the house... Read More
How It Works